on all orders above $300.00

FREE Pills!

via4gra pills

for free with every order



Less than in your
local pharmacy

Search by letter:

Coumadin (Warfarin)

Rating of sales:          


Coumadin is a medication of high quality which is taken in treatment of blood clots in arteries and veins (venous thrombosis) and in the lung (pulmonary embolism), strokes, heart seizures. It is also taken by patients with prosthetic heart valves. Coumadin is acting by making inability of blood to form the clots.

Other names for this medication:
Aldocumar, Anasmol, Arefarin, Choice, Circuvit, Coumadine, Coumafene, Cumar, Farevan, Fargem, Farin, Hemeran, Jantoven, Kovar, Lawarin, Marevan, Marfarin, Marivarin, Martefarin, Orfarin, Panwarfin, Simarc, Uniwarfin, Warafin, Waran, Warfant, Warfarex, Warfarina, Warfarine, Warfarinum, Warfilone, Warfin, Warin, Warlin

Similar Products:
Cartia Xt, Plavix

30 pills
When you purchase you get a bonus:
Cialis Soft
Cialis Soft 20mg
or Viagra Soft
Viagra Soft 100mg

You can choose your bonus in the shopping cart before checkout.

   bonus pills



USD 1.42 per pill   -20% USD 53.15 USD 42.52 per 30 pills   Order now
60 pills
When you purchase you get a bonus:
Cialis Soft
Cialis Soft 20mg
or Viagra Soft
Viagra Soft 100mg

You can choose your bonus in the shopping cart before checkout.

   bonus pills



USD 1.09 per pill   -20% USD 81.90 USD 65.52 per 60 pills   Order now
90 pills
When you purchase you get a bonus:
Cialis Soft
Cialis Soft 20mg
or Viagra Soft
Viagra Soft 100mg

You can choose your bonus in the shopping cart before checkout.

   bonus pills



USD 1.03 per pill   -20% USD 115.76 USD 92.61 per 90 pills   Order now
120 pills
When you purchase you get a bonus:
Cialis Soft
Cialis Soft 20mg
or Viagra Soft
Viagra Soft 100mg

You can choose your bonus in the shopping cart before checkout.

   bonus pills



USD 0.99 per pill   -20% USD 148.05 USD 118.44 per 120 pills   Order now
180 pills
When you purchase you get a bonus:
Cialis Soft
Cialis Soft 20mg
or Viagra Soft
Viagra Soft 100mg

You can choose your bonus in the shopping cart before checkout.

   bonus pills



USD 0.96 per pill   -20% USD 214.99 USD 171.99 per 180 pills   Order now

Also known as:  Warfarin.


Coumadin target is the treatment of blood clots in arteries and veins (venous thrombosis) and in the lung (pulmonary embolism), strokes, heart seizures. It is also taken by patients with prosthetic heart valves. Coumadin is acting by making inability of blood to form the clots. It is anticoagulant ('blood thinner').

Generic name of Coumadin is Warfarin.

Coumadin is also known as Warfarin sodium, Warf, Jantoven, Marevan, Waran.

Brand name of Coumadin is Coumadin.


Take Coumadin at the same time every day.

Take Coumadin tablets orally with water, once a day, with or without food.

If you want to achieve most effective results do not stop taking Coumadin suddenly.


If you overdose Coumadin and you don't feel good you should visit your doctor or health care provider immediately. Symptoms of Coumadin overdosage: round, small, red spots under the skin, painful menstruation, bruising, minor cuts bleeding, gums bleeding, bloody stools, heavy bleeding.


Store at room temperature between 15 and 30 degrees C (59 and 86 degrees F) away from moisture, light and heat. Throw away any unused medicine after the expiration date. Keep out of the reach of children.

Side effects

The most common side effects associated with Coumadin are:

  • coumadin generic name
  • coumadin missed dose
  • coumadin 7 mg
  • coumadin 750 mg
  • coumadin dosage guidelines
  • coumadin dosing guideline
  • coumadin and alcohol
  • coumadin po dose
  • coumadin dosing guidelines
  • coumadin 8 mg
  • coumadin tab colors
  • coumadin medication errors
  • coumadin dosing protocol
  • coumadin yellow pill
  • coumadin dosing chart
  • coumadin heart medicine
  • coumadin 1mg tablets
  • coumadin tablet colors
  • coumadin dosing instructions
  • daily dose coumadin
  • coumadin dosing schedule
  • coumadin dosing algorithm
  • coumadin dosing regimen
  • coumadin 5 mg
  • coumadin y alcohol
  • coumadin drug test
  • coumadin dosing
  • coumadin alternative drugs
  • coumadin medication interactions
  • coumadin 3 mg
  • coumadin drug class
  • coumadin reversal medication
  • coumadin cost
  • coumadin dosing uptodate
  • coumadin generic warfarin
  • coumadin drug
  • coumadin 10 mg
  • coumadin dosing 5mg
  • coumadin normal dosage
  • coumadin medication
  • coumadin dosage chart
  • coumadin 75 mg
  • coumadin 15 mg
  • coumadin drug interactions
  • coumadin overdose signs
  • coumadin overdose treatment
  • coumadin dosing calculator
  • coumadin 6mg tab
  • coumadin with alcohol
  • coumadin new drug
  • coumadin replacement drug
  • coumadin pill colors
  • coumadin drug guide
  • coumadin 4mg tablet
  • coumadin overdose seizures
  • coumadin prices
  • coumadin overdose management
  • coumadin 2 mg
  • antidote coumadin overdose
  • coumadin overdose emedicine
  • coumadin levels medication
  • coumadin dosing guide
  • coumadin 4 mg
  • coumadin usual dosage
  • coumadin dosage
  • coumadin reversal drug
  • coumadin 60 mg
  • jantoven medication coumadin
  • coumadin 20 mg
  • coumadin dosing nomogram
  • coumadin 50 mg
  • coumadin dosage protocol
  • coumadin heart medication
  • coumadin 40 mg
  • coumadin daily dose
  • coumadin drug card
  • coumadin alternatives drugs
  • coumadin overdose
  • coumadin overdose death
  • coumadin dose colors
  • coumadin generic
  • coumadin pills
  • coumadin 80 mg
  • coumadin tablets
  • coumadin 6 mg
  • coumadin 9 mg
  • coumadin medicine
  • coumadin medication guide
  • coumadin dosage colors
  • coumadin 5 pill
  • coumadin 3mg tablet
  • coumadin brand name
  • coumadin 1 mg
  • coumadin 30 mg

Side effect occurrence does not only depend on medication you are taking, but also on your overall health and other factors.


Do not take Coumadin if you are allergic to its components.

Do not take Coumadin if you're pregnant or you plan to have a baby, or you are a nursing mother.

Do not take Coumadin if you suffer from or have a history of heart infection, stomach ulcer or bleeding, anemia, hemophilia, fluid or swelling around your heart, blood clot or aneurysm in the brain.

Do not take Coumadin if you are under 18 years. It can be taken by adults over 18 years.

Do not take this medicine if you are taking non-steroidal anti-inflammatory drugs (NSAIDs) such as naproxen (Naprosyn, Aleve), indomethacin, diclofenac (Voltaren), piroxicam (Feldene), ibuprofen (Advil, Motrin), celecoxib (Celebrex).

Be careful with Coumadin if you suffer from or have a history of high blood pressure, cancer, seizure disorder, polycythemia vera, celiac sprue, heart failure, thyroid condition, kidney or liver disease, severe diabetes.

Elderly people should be very careful with Coumadin and its dosage.

Be careful with Coumadin if you are going to have a surgery or take antibiotics.

Avoid food with large amounts of Vitamin K (green vegetables, liver and other) and cranberry.

Avoid food sport activities.

Avoid alcohol and smoking cigarettes while taking Coumadin because it can cause side effects.

Do not stop taking Coumadin suddenly.

coumadin usual dosage

Curative intermediate-term outcomes are possible in dogs undergoing open tricuspid valve replacement with a bioprosthesis. Prosthesis-related complications include inflammatory pannus, thrombosis, and endocarditis. Postoperative atrial fibrillation or flutter can be reduced or prevented by prophylactic preoperative treatment with amiodarone. Several identified complications are avoidable or can be reduced with increased awareness and experience with these techniques.

coumadin overdose management

This study was performed to ascertain the incidence of anticoagulant use in oculoplastic surgical patients and the reliability of patient medication disclosure. Differences in perioperative bleeding complications among patients continuing anticoagulants, those who withheld the medications, and those not anticoagulated were investigated.

coumadin dosing protocol

During follow-up bleedings occurred in 47 (60.3%) patients, 26 patients (33.3%) had recurrent bleedings at therapeutic INR and 21 patients (26.9%) had single bleeding. Mean time in therapeutic range (TTR) was >70.

coumadin dosing uptodate

An ANN was applied to develop a warfarin dosing algorithm. The proposed dosing algorithm has the potential to recommend warfarin dosages that are close to the appropriate dosages.

coumadin dosage chart

This study sought to investigate the outcomes following cardioversion or catheter ablation in patients with atrial fibrillation (AF) treated with warfarin or rivaroxaban.

coumadin brand name

Our objective was to determine the rate of intracranial bleeding in anticoagulated patients with minor and minimal head injuries and the association with clinical features and international normalized ratio (INR).

coumadin drug test

The prospective use of the first-generation American Academy of Orthopaedic Surgeons guidelines resulted in a low incidence of clinically important thromboembolic events in total hip and total knee arthroplasty patients. When properly used in these patients, the guidelines to minimize adverse outcomes are executable and effective.

coumadin with alcohol

Our aim was to identify risk factors for acute gastrointestinal (GI) bleeding in patients with myocardial infarction (MI) who were prescribed clopidogrel following hospital discharge.

coumadin 9 mg

To compare the bleeding risk after cold snare polypectomy or conventional polypectomy for small colorectal polyps in anticoagulated patients.

coumadin drug card

Despite increasing scientific investigation, the best method for preventing postoperative thromboembolism in patients undergoing a total hip replacement (THR) remains unclear. National Institute for Health and Clinical Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN) guidelines on the prevention of thromboembolism have caused much controversy. We surveyed Scottish surgeons regarding their thromboprophylaxis prescribing after THR. Questionnaires were sent to all Scottish orthopaedic consultants. They were asked about routine pharmacological and mechanical prophylaxis in patients undergoing a THR. Comparison was made with a previous survey done in 2003. The response rate was 75%. The survey showed an increased use of pharmacological prophylaxis from 93% to 100%. This was due to the increased use of aspirin from 51% to 64%. The use of low molecular weight heparin has remained constant at 51%. No surgeons routinely use warfarin, un-fractionated heparin or fondaparinux. Use of graded compression stockings has increased from 59% to 70%. In conclusion, there is increasing evidence that patients undergoing THR should receive extended prophylaxis for up to 35 days. Oral agents such as dabigatran and rivaroxaban have offered a new option for oral extended prescribing. The results in change of practice must be closely audited.

coumadin overdose emedicine

Eighteen consecutive patients receiving long-term stable warfarin therapy were enrolled in this study. AZ-ER was administered 1 hour prior to tooth extraction. The international normalized ratio (INR) value was measured prior to AZ-ER administration as well as during, 1 day after, and 7 days after the tooth extraction. Additionally, the azithromycin concentration in the extraction wound as well as in the peripheral venous blood was assessed.

coumadin new drug

NVAF patients ≥ 18 years of age with continuous insurance coverage were identified (January 1, 2007, to December 31, 2009) from the MarketScan Commercial and Medicare Research databases. Patients with 1 inpatient or 2 outpatient dyspepsia diagnoses within 12 months following any NVAF diagnosis were grouped into the dyspeptic cohort, and patients without any dyspepsia diagnosis were grouped into the nondyspeptic cohort. Of the overall cohorts, patients were matched by key patient characteristics. Dyspepsia was further categorized as having a prior history of dyspepsia (chronic) or no dyspepsia (nonchronic) during the baseline period. Health care resource utilization, associated costs, and warfarin use were evaluated during a 12-month follow-up period.

coumadin generic warfarin

In the Randomized Evaluation of Long-term Anticoagulant Therapy (RE-LY) trial, dabigatran 150 mg was shown to be superior to warfarin for the prevention of stroke or systemic embolism. However, there are some concerns with the RE-LY trial, such as its open-label design, potential unblinding of "blinded" adjudicators, the use of concomitant warfarin-aspirin (ASA), the disparity between baseline use of nonselective NSAIDs; the high unequal rate of drop-outs; unaccounted drop-ins; high rates of major bleeds in warfarin-treated patients, despite being a low risk population; and rates of major bleeds that do not match historic warfarin trials. Furthermore, although dabigatran offers potential advantages versus warfarin, there are disadvantages that must be taken into consideration before a patient is switched from the latter to the former. This review will summarize the flaws of the RE-LY trial as well as the clinically important advantages and disadvantages of dabigatran and warfarin.

coumadin normal dosage

Only one-fifth of patients who present with chest pain or suspected ACS have ACS as their final diagnosis. Our new guideline proposal is highly specific and would minimize unnecessary administration of potent anti-thrombotic therapy to low risk patients.

coumadin overdose

Advanced age alone should not exclude the use of dabigatran. Clinicians should base their decision on patient characteristics and careful assessment of risk versus benefit.

Target Point Shipping Method Tracking Delivery Time Price
Worldwide shipping

Worldwide shipping

Registered Mail  Not trackable 14-21 business days USD 20.00 per order
EMS  Trackable, where available 5-9 business days USD 30.00 per order

Delivery time is:

Registered Mail - 14-21 business days, prices - USD 20.00, no signature is required on delivery.
EMS - 5-9 business days, prices - USD 30.00, signature is required on delivery.
Your order will be packed safe and secure and dispatched within 24 hours.

front back side

This is exactly how your parcel will look like (pictures of a real shipping item). It has a look of a regular private letter and does not disclose its contents. Size - 9.4x4.3x0.3 inches (24x11x0.7cm).

 Show Hide 
coumadin 4mg tablet 2016-12-07

Administration of FEIBA does not appear to increase the risk of thrombotic events compared with FFP. FEIBA administration resulted in faster INR reversal with a trend toward shorter time to neurosurgical intervention. However, there Duloxetine Cymbalta Dosage was no difference in hematoma expansion, mortality or length of stay.

coumadin 1mg tablets 2015-06-27

The efficacy and safety of dabigatran for treatment of venous thromboembolism (VTE) were demonstrated in two trials. It is unclear if the results pertain to patients with cancer and VTE. Data from two randomised trials comparing dabigatran and warfarin for acute VTE were pooled. Primary efficacy outcome was symptomatic recurrent VTE and related death from randomisation to the end of the treatment period. Safety outcomes were major, major and clinically relevant non-major, and any bleeding during the oral-only treatment period. Patients with active cancer (=within 5 years) at baseline or diagnosed during the study were analysed. Compared with 4,772 patients without cancer, recurrent VTE occurred more frequently in 335 patients with cancer at any time (hazard ratio [HR] 3.3; 95 % confidence interval [CI], 2.1-5.3) and more often in 114 with cancer diagnosed during the study compared to 221 with cancer at baseline (HR 2.6; 95 % CI, 1.1-6.2). There was no significant difference in efficacy between dabigatran and warfarin for cancer at baseline (HR 0.75; 95 % CI, 0.20-2.8) or diagnosed during the study (HR 0.63; 95 % CI, 0.20-2.0). Major bleeding (HR 4.1; 95 % CI, 2.2-7.5) and any bleeding (HR 1.5; 95 % CI, 1.2-2.0) were more frequent in patients with cancer than without, but with similar incidence in cancer with dabigatran or warfarin. In conclusion, in cancer patients, dabigatran provided similar clinical benefit Periactin Buy as warfarin. VTE recurrence or bleeding were similar in patients on dabigatran or warfarin. The efficacy of dabigatran has not been assessed in comparison with low-molecular-weight heparin.

coumadin generic name 2015-11-10

Opinions of current VKA therapy, level of awareness of NOACs, and ratings of potential benefits and deterrents of Valtrex 800 Mg transition to NOACs were sought.

coumadin 3mg tablet 2015-04-21

While age was associated with outcome, we were unable to demonstrate any other early factors that were associated with long-term functional outcome Buy Duricef Online in elderly patients that underwent a cranial operation for TBI.

coumadin medication 2017-08-14

It is critical for physicians involved in the care of patients with CHI on dabigatran to Cymbalta Alcohol Blackouts be aware of an elevated mortality rate if no treatment protocol or guideline is in place. The authors will soon implement a reversal management protocol for patients with CHI on dabigatran at their institution in an attempt to improve efficacy and safety in their treatment approach.

coumadin drug 2016-05-26

A rare but described risk Buspar Overdose factor for deep venous thrombosis (DVT), predominantly in the young, is congenital agenesis or atresia of the inferior vena cava (IVC). The optimal management for DVT in this subset of patients is unknown. We evaluated the efficacy of pharmacomechanical catheter-directed thrombolysis (PCDT) followed by systemic anticoagulation in the treatment of acute lower-extremity DVT in the setting of congenital IVC agenesis or atresia.

coumadin po dose 2017-09-03

Warfarin is a widely used oral anticoagulant. It is highly efficacious for the treatment and prevention of thromboembolic disorders despite its narrow therapeutic window. Poor compliance with warfarin is common and a major contributor to poor anticoagulation control. A number of psychosocial issues (e.g. depressive symptoms, attitudinal and behavioral factors, cognitive function, lack of social support, limited English proficiency, health illiteracy) have been associated with warfarin non-compliance among patients in anticoagulation clinics. Patient-specific features, such as these, are important to identify in Celexa Missed Dose order to develop appropriate and practical interventions. Health literacy and limited English proficiency are the extension of issues related to culture, language, and ethnicity. A better understanding of patients' functioning level and health utilization factors may help to develop and target interventions for high risk patients and reduce complications from suboptimal therapy and poor warfarin management due to non-compliance. Four patient case scenarios will be used to illustrate these issues and identify potential interventions to optimize warfarin therapy.

coumadin normal dosage 2015-12-10

Not more effective than warfarin in three "non-inferiority" trials. Less Ponstel Cost bleeding but more acute coronary events with dabigatran, and still no antidote.

coumadin 10 mg 2016-10-24

Published data on the association between vitamin K epoxide reductase complex 1 (VKORC1)-1639G > A polymorphism and warfarin dose requirement are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed.

coumadin new drug 2016-07-24

A potential interaction involving therapeutic doses of ascorbic acid and warfarin is described.

coumadin drug guide 2017-06-19

Venous thromboembolism (VTE) is a disease spectrum that ranges from deep vein thrombosis (DVT) to pulmonary embolism (PE). Rapid diagnosis and treatment of VTE by emergency care providers are critical for decreasing patient mortality, morbidity, and the incidence of recurrent events. Recent American College of Chest Physicians guidelines recommend initial treatment with unfractionated heparin, low-molecular weight heparin, or fondaparinux overlapped with warfarin for a minimum of 5 days for the treatment of VTE in most cases. Warfarin monotherapy is thereafter continued for 3, 6, or 12 months. These guidelines were published before the approval of target-specific oral anticoagulants (TSOACs), and they have yet to be updated to reflect these new treatment options. For some patients, TSOACs, which act by directly inhibiting factor IIa or factor Xa, may provide safer, more convenient alternatives to warfarin. Their advantages include ease of use, reduced monitoring requirements, and lower bleeding risk than traditional therapy. Additionally, clinical trials have established noninferiority of TSOACs to warfarin for the prevention of recurrent VTE. These trials have demonstrated that TSOACs exhibit similar or lower bleeding rates, particularly intracranial bleeding rates compared with warfarin. Anticoagulation therapy with TSOACs may allow early discharge or outpatient management options for low-risk patients with DVT and PE. This review addresses the importance of early diagnosis and treatment of VTE, outcomes of VTE risk assessment, key efficacy and safety data from phase 3 clinical trials for the various TSOACs for the treatment of DVT and PE, and the corresponding considerations for clinical practice.